CRNX logo

CRNX

Profile

Full Name

Crinetics Pharmaceuticals, Inc.

Ticker Symbol

CRNX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 18, 2018

Indexes

Not included

Website

http://www.crinetics.com

Employees

437

Key Details

Price

$28.87

Market Cap

$2.69B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$1.04M(-74.11% YoY)

Annual EPS

-$3.69(0.00% YoY)

PE Ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$28.87
CRNX price is $28.87

Price All-time High

$63.01
CRNX price is currently -54.18% below its historical high of $63.01

Price Most Recent Change

-6.87%
CRNX price was down -6.87% on Apr 3, 2025

Price YTD Change

-43.54%
CRNX price is down -43.54% since January 1st

Price 1-year Change

-39.73%
CRNX price is down -39.73% year-on-year

Price 3-year Change

+22.43%
CRNX price is up +22.43% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$2.69B
CRNX market capitalization is $2.69 billion

Market Cap 3-year Change

+138.33%
CRNX market capitalization is up +138.33% over the past 3 years

Market Cap All-time High

$5.84B
CRNX market capitalization is currently -54.03% below its historical high of $5.84 billion

Market Cap Sector Rank

85.23%
CRNX market capitalization is higher than 85.23% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+18.47%
CRNX shares outstanding is up +18.47% year-on-year

Shares Outstanding 3-Year Change

+94.66%
CRNX shares outstanding is up +94.66% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.29
CRNX beta is 1.29

200-day SMA

$48.06
CRNX price is currently -39.93% below its 200-day simple moving average

50-day SMA

$35.51
CRNX price is currently -18.70% below its 50-day simple moving average

RSI

29.66
CRNX 14-day relative strength index is 29.66

Volume

1.00
CRNX 30-day relative volume is 1.00

ATR

$1.89
CRNX average true range is $1.89

10-day Historical Volatility

67.18%
CRNX 10-day historical volatility is 67.18%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.04M
CRNX annual revenue is $1.04 million

Revenue Analysts Estimate

$6.07M
CRNX annual revenue is currently -82.87% lower than the consensus analysts' forecast

Revenue 1-year Change

-74.11%
CRNX annual revenue is down -74.11% year-on-year

Revenue Sector Rank

16.31%
CRNX annual revenue is higher than 16.31% of companies in Healthcare sector

EPS

EPS

-$3.69
CRNX annual earnings per share is -$3.69

EPS Analysts Estimate

-$4.17
CRNX annual earnings per share is currently -11.54% lower than the consensus analysts' forecast

EPS 1-year Change

0%
CRNX {parameterFullLabel} has remained unchanged year-on-year

EPS Sector Rank

24.22%
CRNX annual earnings per share is higher than 24.22% of companies in Healthcare sector

Profit

Gross Profit

-
CRNX annual gross profit value is unknown

Gross Margin

-
CRNX annual gross profit margin value is unknown

Operating Profit

-$338.85M
CRNX annual operating income is -$338.85 million

Operating Margin

-32.61K%
CRNX annual operating profit margin is -32.61 thousand%

Net Income

-$298.41M
CRNX annual net profit is -$298.41 million

Net Margin

-28.72K%
CRNX annual net profit margin is -28.72 thousand%

Expenses

Total Expenses

$339.89M
CRNX annual total expenses is $339.89 million

Operating Expenses

$339.89M
CRNX annual total operating expenses is $339.89 million

Cost Of Goods Sold

-
CRNX annual cost of goods sold value is unknown

Selling, General & Administrative Expenses

$99.74M
CRNX annual SGA is $99.74 million

Depreciation And Amortization

$2.79M
CRNX annual depreciation & amortization is $2.79 million

Interest Expense

-
CRNX annual interest expense value is unknown

Income Tax

-
CRNX annual income tax value is unknown

EBIT & EBITDA

EBIT

-$338.85M
CRNX annual earnings before interest & taxes is -$338.85 million

EBITDA

-$336.07M
CRNX annual EBITDA is -$336.07 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$1.43B
CRNX annual total assets is $1.43 billion

Non Current Assets

$59.20M
CRNX annual long term assets is $59.20 million

Current Assets

$1.38B
CRNX annual total current assets is $1.38 billion

Cash And Cash Equivalents

$264.55M
CRNX annual cash & cash equivalents is $264.55 million

Accounts Receivable

-
CRNX annual accounts receivable value is unknown

Inventory

-
CRNX annual inventory value is unknown

Liabilities

Total Liabilities

$109.79M
CRNX annual total liabilities is $109.79 million

Long Term Liabilities

$50.10M
CRNX annual total long term liabilities is $50.10 million

Current Liabilities

$59.68M
CRNX annual total current liabilities is $59.68 million

Accounts Payable

$5.85M
CRNX annual accounts payable is $5.85 million

Debt

Total Debt

$51.72M
CRNX annual total debt is $51.72 million

Total Debt 1-year Change

-0.01%
CRNX annual total debt is down -0.01% year-on-year

Long Term Debt

$44.57M
CRNX annual long term debt is $44.57 million

Short Term Debt

$7.15M
CRNX annual short term debt is $7.15 million

Equity & Capital

Shareholders Equity

$1.32B
CRNX annual stockholders equity is $1.32 billion

Book Value

$1.32B
CRNX annual book value is $1.32 billion

Retained Earnings

-$952.11M
CRNX annual retained earnings is -$952.11 million

Working Capital

$1.32B
CRNX annual working capital is $1.32 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

-$225.97M
CRNX annual cash flow from operations is -$225.97 million

Cash From Operations 1-year Change

-35.88%
CRNX annual cash flow from operations is down -35.88% year-on-year

Cash From Investing

-$574.82M
CRNX annual cash flow from investing activities is -$574.82 million

Cash From Investing 1-year Change

-186.82%
CRNX annual cash flow from investing activities is down -186.82% year-on-year

Cash From Financing

$1.01B
CRNX annual cash flow from financing activities is $1.01 billion

Cash From Financing 1-year Change

+159.79%
CRNX annual cash flow from financing activities is up +159.79% year-on-year

CAPEX

CAPEX

$3.84M
CRNX annual capital expenditures is $3.84 million

CAPEX 1-year Change

-18%
CRNX annual capital expenditures is down -18% year-on-year

Free Cash Flow

Free Cash Flow

-$229.81M
CRNX annual free cash flow is -$229.81 million

Free Cash Flow 1-year Change

-34.4%
CRNX annual free cash flow is down -34.4% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

-
CRNX annual gross profit margin value is unknown

Operating Margin

-32.61K%
CRNX annual operating profit margin is -32.61 thousand%

Net Margin

-28.72K%
CRNX annual net profit margin is -28.72 thousand%

ROA & ROE

ROA

-28.83%
CRNX annual return on assets is -28.83%

ROE

-32.02%
CRNX annual return on equity is -32.02%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
CRNX price to earnings ratio value is unknown

PE Ratio Sector Rank

-
CRNX price to earnings ratio is unknown

PB Ratio

PB Ratio

2.03
CRNX price to book ratio is 2.03

PB Ratio Sector Rank

63.22%
CRNX price to book ratio is higher than 63.22% of companies in Healthcare sector

PS Ratio

PS Ratio

-
CRNX price to sales ratio value is unknown

PS Ratio Sector Rank

-
CRNX price to sales ratio is unknown

Enterprise value

Enterprise Value

$2.47B
CRNX enterprise value is $2.47 billion

Enterprise Value Sector Rank

83.71%
CRNX enterprise value is higher than 83.71% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-7.36
CRNX EV/EBITDA is -7.36

EV/EBITDA Sector Rank

14.12%
CRNX EV/EBITDA is higher than 14.12% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

23.04
CRNX annual current ratio is 23.04

Quick Ratio

-
CRNX annual quick ratio value is unknown

Leverage

Debt To Equity

0.00
CRNX annual debt to equity ratio is 0.00

Interest Coverage Ratio

-
CRNX annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CRNX piotroski f-score value is unknown

Altman Z-Score

14.07
CRNX altman z-score is 14.07

Analyst ratings

Recent major analysts updates

Mar 25, 25 Stifel
Buy
Feb 28, 25 Citizens Capital Markets
Market Outperform
Feb 4, 25 Wolfe Research
Peer Perform
Jan 22, 25 Jefferies
Buy
Jan 13, 25 HC Wainwright & Co.
Buy
Dec 16, 24 JMP Securities
Market Outperform
Nov 14, 24 Citigroup
Buy
Nov 13, 24 HC Wainwright & Co.
Buy
Sep 27, 24 JMP Securities
Market Outperform
Sep 16, 24 Cantor Fitzgerald
Overweight

Institutional Ownership

Similar stocks

PRVA logo
Privia Health (PRVA)
ACAD logo
ACADIA Pharmaceuticals (ACAD)
IMVT logo
Immunovant (IMVT)
LFST logo
LifeStance Health (LFST)
ACHC logo
Acadia Healthcare (ACHC)
APLS logo
Apellis Pharmaceuticals (APLS)
VKTX logo
Viking Therapeutics (VKTX)
PDCO logo
Patterson Companies (PDCO)
HCM logo
HUTCHMED (China) Limited (HCM)
  • What is the ticker symbol for Crinetics Pharmaceuticals?
  • Does Crinetics Pharmaceuticals pay dividends?
  • What sector is Crinetics Pharmaceuticals in?
  • What industry is Crinetics Pharmaceuticals in?
  • What country is Crinetics Pharmaceuticals based in?
  • When did Crinetics Pharmaceuticals go public?
  • Is Crinetics Pharmaceuticals in the S&P 500?
  • Is Crinetics Pharmaceuticals in the NASDAQ 100?
  • Is Crinetics Pharmaceuticals in the Dow Jones?
  • When was Crinetics Pharmaceuticals's last earnings report?
  • When does Crinetics Pharmaceuticals report earnings?
  • Should I buy Crinetics Pharmaceuticals stock now?

What is the ticker symbol for Crinetics Pharmaceuticals?

The ticker symbol for Crinetics Pharmaceuticals is NASDAQ:CRNX

Does Crinetics Pharmaceuticals pay dividends?

No, Crinetics Pharmaceuticals does not pay dividends

What sector is Crinetics Pharmaceuticals in?

Crinetics Pharmaceuticals is in the Healthcare sector

What industry is Crinetics Pharmaceuticals in?

Crinetics Pharmaceuticals is in the Biotechnology industry

What country is Crinetics Pharmaceuticals based in?

Crinetics Pharmaceuticals is headquartered in United States

When did Crinetics Pharmaceuticals go public?

Crinetics Pharmaceuticals's initial public offering (IPO) was on July 18, 2018

Is Crinetics Pharmaceuticals in the S&P 500?

No, Crinetics Pharmaceuticals is not included in the S&P 500 index

Is Crinetics Pharmaceuticals in the NASDAQ 100?

No, Crinetics Pharmaceuticals is not included in the NASDAQ 100 index

Is Crinetics Pharmaceuticals in the Dow Jones?

No, Crinetics Pharmaceuticals is not included in the Dow Jones index

When was Crinetics Pharmaceuticals's last earnings report?

Crinetics Pharmaceuticals's most recent earnings report was on Feb 27, 2025

When does Crinetics Pharmaceuticals report earnings?

The next expected earnings date for Crinetics Pharmaceuticals is May 9, 2025

Should I buy Crinetics Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page